{"id":"F2006L03688","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 49 of 2006)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-49-of-2006","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":137447,"registerId":"commonwealth-F2006L03688-current","compilationNumber":null,"startDate":"2026-04-03","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 49 of 2006)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85(2AA)\n\nNo. PB 49 OF 2006\n\nI, JOAN CORBETT, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, having in accordance with subsection 85(2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85(2AA) of the National Health Act 1953 hereby make the following Declaration:\n\n1. This Declaration commences on 1 December 2006.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nBenzyl Benzoate\n\nOestradiol Valerate and Oestradiol Valerate with Cyproterone Acetate\n\n“PK Max”\n\nQuinidine Bisulfate\n\nDated this 7th day of November 2006.\n\nJOAN CORBETT\n\nAssistant Secretary\n\nPharmaceutical Evaluation Branch\n\nDepartment of Health and Ageing\n\nDelegate of the Minister for Health and Ageing","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1503},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"The declaration remains narrowly focused on the specific technical task of delisting four named pharmaceutical products from the PBS. It has not expanded beyond the original scope of the enabling provision."},"complexity_factors":["Extremely short length (single page)","No interpretation section or defined terms","Only one operative clause removing specified items","Minimal cross-referencing (only references the empowering provision section 85(2AA))"],"plain_english_summary":"This declaration removes four medicines from Australia’s Pharmaceutical Benefits Scheme from 1 December 2006 — benzyl benzoate; oestradiol valerate (and its combo with cyproterone acetate); the branded preparation \"PK Max\"; and quinidine bisulfate.  \n\nPatients prescribed these drugs will no longer receive PBS subsidies and must pay the full private price (unless covered elsewhere). The change reflects a Department of Health decision to delist them for cost or clinical-effectiveness reasons."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-49-of-2006","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-49-of-2006/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-49-of-2006/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-49-of-2006/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-49-of-2006/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-49-of-2006/documents"}}